Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Harmony Biosciences Holdings (HRMY) Leases (2020 - 2025)

Harmony Biosciences Holdings' Leases history spans 6 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Leases rose 151.84% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, up 151.84%, while the annual FY2025 figure was $5.3 million, 151.84% up from the prior year.
  • Leases for Q4 2025 was $5.3 million at Harmony Biosciences Holdings, up from $1.2 million in the prior quarter.
  • Across five years, Leases topped out at $5.3 million in Q4 2025 and bottomed at $1.2 million in Q3 2025.
  • The 5-year median for Leases is $2.4 million (2023), against an average of $2.5 million.
  • The largest YoY upside for Leases was 151.84% in 2025 against a maximum downside of 49.08% in 2025.
  • A 5-year view of Leases shows it stood at $3.3 million in 2021, then fell by 29.9% to $2.3 million in 2022, then increased by 1.38% to $2.3 million in 2023, then fell by 9.47% to $2.1 million in 2024, then soared by 151.84% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Leases are $5.3 million (Q4 2025), $1.2 million (Q3 2025), and $1.3 million (Q2 2025).